CN110201087A - A kind of externally applied drug for treating shingles zoster - Google Patents

A kind of externally applied drug for treating shingles zoster Download PDF

Info

Publication number
CN110201087A
CN110201087A CN201910675471.5A CN201910675471A CN110201087A CN 110201087 A CN110201087 A CN 110201087A CN 201910675471 A CN201910675471 A CN 201910675471A CN 110201087 A CN110201087 A CN 110201087A
Authority
CN
China
Prior art keywords
parts
externally applied
shingles zoster
dragon
applied drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910675471.5A
Other languages
Chinese (zh)
Inventor
徐新鹏
岳晓军
徐宝华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201910675471.5A priority Critical patent/CN110201087A/en
Publication of CN110201087A publication Critical patent/CN110201087A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234—Cnidium (snowparsley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718—Coptis (goldthread)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to field of traditional Chinese medicine preparation, i.e., a kind of externally applied drug for treating shingles zoster.It is made of the bulk pharmaceutical chemicals of following parts by weight: 0.5-3 parts of the coptis；0.5-3 parts of Cortex Phellodendri；0.5-3 parts of dandelion；0.5-3 parts of ginseng；0.5-3 parts of frutus cnidii；0.1-2 parts of myrrh；0.1-2 parts of borneol；0.1-2 parts of gypsum；0.1-2 parts of talcum；0.1-2 parts of cuttlebone；0.1-2 parts of corydalis tuber；0.1-2 parts of dragon's blood.Function with the major functions: having effects that clearing heat and detoxicating, activating microcirculation and removing stasis medicinal, antalgesic-antipruritic.Treat shingles zoster.By clinical trial, relieve pain within 10 minutes after coating, blister atrophoderma in 20 hours forms a scab in seven days, decrustation in 15 days.Neuralgia treating sufferings symptom after patient heals can especially be eliminated.Through up to a hundred actual uses of accumulative patient, cure rate 100% is significant in efficacy.

Description

A kind of externally applied drug for treating shingles zoster
Technical field
The present invention relates to field of traditional Chinese medicine preparation, i.e., a kind of externally applied drug for treating shingles zoster.
Background technique
In the prior art, shingles zoster is a kind of infectious diseases for influencing nerve and skin, by varicella-zoster Virus causes, since fash is in zonal distribution, so being called shingles zoster.This kind of disease has certain infectiousness.Shingles zoster Fash usually occur to show as pain in the side of body, move towards the blister being distributed in groups along peripheral nerve, do not span across body The middle line (down to an imaginary line of navel among eyes) of body, can betide Head And Face, neck, chest, abdomen and four limbs.Cause Bleb mostly occurs in waist, civil to be commonly called as herpes zoster.It is curative for effect that shingles symptoms still are directed to without one kind in the market Traditional Chinese medicine for external application.This product can apply in addition can make withered bleb, recession, incrustation heal, and completely eliminate affected part sufferings disease Shape.
Summary of the invention
The object of the present invention is to provide a kind of externally applied drugs for the treatment of shingles zoster significant in efficacy.
The technical solution of the invention is as follows: a kind of externally applied drug for treating shingles zoster, it is characterised in that it is by following heavy The bulk pharmaceutical chemicals of amount number are made: 0.5-3 parts of the coptis；0.5-3 parts of Cortex Phellodendri；0.5-3 parts of dandelion；0.5-3 parts of ginseng；Frutus cnidii 0.5-3 parts；0.1-2 parts of myrrh；0.1-2 parts of borneol；0.1-2 parts of gypsum；0.1-2 parts of talcum；0.1-2 parts of cuttlebone；Corydalis tuber 0.1-2 parts；0.1-2 parts of dragon's blood.
It is preferred that a kind of externally applied drug for treating shingles zoster, it is characterised in that it is made of the bulk pharmaceutical chemicals of following parts by weight: 0.5 part of the coptis；0.5 part of Cortex Phellodendri；0.5 part of dandelion；0.5 part of ginseng；0.5 part of frutus cnidii；0.1 part of myrrh；0.1 part of borneol；Stone 0.1 part of cream；0.1 part of talcum；0.1 part of cuttlebone；0.1 part of corydalis tuber；0.1 part of dragon's blood.
A kind of preparation method of externally applied drug that treating shingles zoster, it is characterised in that steps are as follows: the coptis, Cortex Phellodendri, Pu Gong English, ginseng, frutus cnidii, myrrh, borneol, corydalis tuber, dragon's blood ethyl alcohol sealing 48 hours (effective component is allowed to discharge) of submergence；It takes out dry It is dry, be crushed to no less than 120 mesh；Again by gypsum, talcum, cuttlebone, dragon's blood co-grinding to no less than 120 mesh；All stirrings Pulvis finished product is made after mixing.
Our institute's medication, using the clearing heat and detoxicating coptis, Cortex Phellodendri, dandelion as monarch drug in a prescription.To nourish vigour, veins takes off admittedly, life The ginseng that saliva is calmed the nerves is ministerial drug.With inducing resuscitation of having one's ideas straightened out, frutus cnidii, the myrrh, borneol, cuttlebone, member of activating microcirculation and removing stasis medicinal, hygroscopic analgesic Recklessly, dragon's blood is adjutant.The effect of being to make medicine with gypsum, talcum, realizing clearing heat and detoxicating, activating microcirculation and removing stasis medicinal, antalgesic-antipruritic.
Function with the major functions: having effects that clearing heat and detoxicating, activating microcirculation and removing stasis medicinal, antalgesic-antipruritic.Treat shingles zoster.
Usage: paste is made in we with physiological saline, is applied to affected part.3 times a day.
Pharmaceutical dosage form is without being limited thereto, by (pharmacy) common pharmaceutical carrier on above-mentioned each medicinal raw material and pharmacy, such as figuration Agent or acceptable auxiliary material can be mixed tablet, capsule (soft capsule), granule, powder, pill, liquid preparation or Other conventional formulations.
Advantages of the present invention: the present invention is secret prescription handed down in the family from generation to generation, processes by modernization process, is allowed to more scientific complete.Especially It is that the coptis, Cortex Phellodendri, dandelion externally treating herpes zoster are not recorded still.Frutus cnidii, myrrh, borneol, corydalis tuber, dragon's blood synthesis make With also not finding clinical record.By clinical trial, relieving pain within 10 minutes after coating, blister atrophoderma in 20 hours forms a scab in seven days, Decrustation in 15 days.Neuralgia treating sufferings symptom after patient heals can especially be eliminated.Patient's names up to a hundred are practical makes through accumulative With, decrustation in 15 days, cure rate 100% is significant in efficacy.
Specific embodiment
Embodiment 1
A kind of externally applied drug for treating shingles zoster, it is characterised in that it is made of the bulk pharmaceutical chemicals of following parts by weight: the coptis 0.5 Part；0.5 part of Cortex Phellodendri；0.5 part of dandelion；0.5 part of ginseng；0.5 part of frutus cnidii；0.1 part of myrrh；0.1 part of borneol；0.1 part of gypsum； 0.1 part of talcum；0.1 part of cuttlebone；0.1 part of corydalis tuber；0.1 part of dragon's blood.
Embodiment 2
A kind of externally applied drug for treating shingles zoster, it is characterised in that it is made of the bulk pharmaceutical chemicals of following parts by weight: 1 part of the coptis； 1 part of Cortex Phellodendri；1 part of dandelion；0.5 part of ginseng；0.5 part of frutus cnidii；0.1 part of myrrh；0.1 part of borneol；0.1 part of gypsum；Talcum 0.1 Part；0.1 part of cuttlebone；0.1 part of corydalis tuber；0.1 part of dragon's blood.
Embodiment 3
A kind of externally applied drug for treating shingles zoster, it is characterised in that it is made of the bulk pharmaceutical chemicals of following parts by weight: 3 parts of the coptis； 3 parts of Cortex Phellodendri；3 parts of dandelion；1 part of ginseng；1 part of frutus cnidii；1 part of myrrh；1 part of borneol；1 part of gypsum；1 part of talcum；Cuttlebone 1 Part；1 part of corydalis tuber；1 part of dragon's blood.
Experimental example
Using 1 medication of embodiment, through up to a hundred actual uses of accumulative patient, decrustation in 15 days is all cured, cure rate 100%, it is significant in efficacy.
Diagnosis:
It is in zonal distribution along side peripheral nerve 1. gathering blister in groups occurs in affected skin.
2. having apparent neuralgia, with regional glandular enlargement.
3. intermediate skin is normal.
Usage: paste is made in we with physiological saline, is applied to affected part.3 times a day.
Curative effect judging standard
It cures fash all to subside, subjective symptoms disappears, and does not stay any sequelae.Improvement fash largely subsides, conscious disease Shape mitigates. 
In vain through treatment 1 week or more, fash and subjective symptoms are not felt any better person.
It is described above, only a specific embodiment of the invention, it is various to illustrate not content structure for the essence of the present invention At limitation.

Claims (4)

1. a kind of externally applied drug for treating shingles zoster, it is characterised in that it is made of the bulk pharmaceutical chemicals of following parts by weight: the coptis 0.5-3 parts；0.5-3 parts of Cortex Phellodendri；0.5-3 parts of dandelion；0.5-3 parts of ginseng；0.5-3 parts of frutus cnidii；0.1-2 parts of myrrh；Borneol 0.1-2 parts；0.1-2 parts of gypsum；0.1-2 parts of talcum；0.1-2 parts of cuttlebone；0.1-2 parts of corydalis tuber；0.1-2 parts of dragon's blood.
2. a kind of externally applied drug for treating shingles zoster as described in claim 1, it is characterised in that it is by following parts by weight Bulk pharmaceutical chemicals are made: 0.5 part of the coptis；0.5 part of Cortex Phellodendri；0.5 part of dandelion；0.5 part of ginseng；0.5 part of frutus cnidii；0.1 part of myrrh；Ice 0.1 part of piece；0.1 part of gypsum；0.1 part of talcum；0.1 part of cuttlebone；0.1 part of corydalis tuber；0.1 part of dragon's blood.
3. a kind of externally applied drug for treating shingles zoster as claimed in claim 1 or 2, it is characterised in that containing pharmaceutically acceptable Auxiliary material.
4. a kind of preparation method for the externally applied drug for treating shingles zoster as claimed in claim 1 or 2, it is characterised in that step is such as Under: the coptis, Cortex Phellodendri, dandelion, ginseng, frutus cnidii, myrrh, borneol, corydalis tuber, dragon's blood seal submergence 48 hours with ethyl alcohol；It takes out Drying is crushed to no less than 120 mesh；Again by gypsum, talcum, cuttlebone, dragon's blood co-grinding to no less than 120 mesh；All stir Mix finished product after mixing.
CN201910675471.5A 2019-07-25 2019-07-25 A kind of externally applied drug for treating shingles zoster Pending CN110201087A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910675471.5A CN110201087A (en) 2019-07-25 2019-07-25 A kind of externally applied drug for treating shingles zoster

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910675471.5A CN110201087A (en) 2019-07-25 2019-07-25 A kind of externally applied drug for treating shingles zoster

Publications (1)

Publication Number Publication Date
CN110201087A true CN110201087A (en) 2019-09-06

Family

ID=67797950

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910675471.5A Pending CN110201087A (en) 2019-07-25 2019-07-25 A kind of externally applied drug for treating shingles zoster

Country Status (1)

Country Link
CN (1) CN110201087A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110448516A (en) * 2019-09-27 2019-11-15 徐新鹏 A kind of Chinese materia medica preparation composition brightening smoothing wrinkle

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103977194A (en) * 2014-05-26 2014-08-13 通化昌源医药科技有限公司 Application of drug for external use capable of effectively treating wound infection in preparing medicaments for treating diabetic foot

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103977194A (en) * 2014-05-26 2014-08-13 通化昌源医药科技有限公司 Application of drug for external use capable of effectively treating wound infection in preparing medicaments for treating diabetic foot

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110448516A (en) * 2019-09-27 2019-11-15 徐新鹏 A kind of Chinese materia medica preparation composition brightening smoothing wrinkle

Similar Documents

Publication Publication Date Title
CN1129130A (en) Medicament for treatment of cervical spondylopathy
CN102247501A (en) Medicine for treating soft tissue injury
CN110201087A (en) A kind of externally applied drug for treating shingles zoster
CN100431593C (en) Chinese medicinal formulation for treating hydrocephalus
CN104771602A (en) Medicine for treating facioplegia and preparation method thereof
CN102145101A (en) Novel traditional Chinese medicine for treating rheumatic lumbocrural pains
CN102274372B (en) Traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage
CN101757311B (en) Traditional Chinese medicine capsule for treating knee osteoarthritis
CN108175784A (en) A kind of Chinese medicine composition of rheumatism treating and its medicament preparation method
CN1943635B (en) Chinese traditional medicinal preparation for treating bone injuries and osteonosus
CN1846756A (en) Amber bolus
CN101983666A (en) Traditional Chinese medicine composition for treating rheumatism and preparation method thereof
CN108066738B (en) Ointment for treating gouty arthritis and preparation method thereof
CN1411861A (en) Medicine for curing acute injury of muscle and tendon and its preparation method
RU2076731C1 (en) Agent and method of organism nonspecific resistance increase at viscera morbidity
CN102614252B (en) Prescription for treating cataract
CN111700961A (en) Medicine for treating rheumatic ostealgia
CN1814104A (en) Wind-repellent collateral-flow-activating pain-relieving medicine of Radix seu Folium Lobeliae Seguinit
CN105617214A (en) Traditional Chinese medicine composition for treating scabies
CN103251851B (en) Internal and external traditional Chinese medicine formulation for treating rheumatic and rheumatoid diseases
CN1201764C (en) Chinese medicine oil preparation for promoting blood circulation
CN105267411B (en) A kind of pharmaceutical composition for treating fracture
CN101716275B (en) Chinese patent medicament for treating osteomyelitis and preparation method
CN116492409A (en) Tibetan medicinal composition for treating rheumatism
CN1387887A (en) Chinese medicine prepn for treating arterioscleriosis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190906